Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Danaher Corp Stock Research

DHR

248.18USD-1.45(-0.58%)Market Closed
Watchlist

Market Summary

USD248.18-1.45
Market Closed
-0.58%

DHR Alerts

  • 1 major insider sales recently.
  • Big fall in earnings (Y/Y)

DHR Stock Price

DHR RSI Chart

DHR Valuation

Market Cap

184.3B

Price/Earnings (Trailing)

28.97

Price/Sales (Trailing)

6.07

EV/EBITDA

21.2

Price/Free Cashflow

25.59

DHR Price/Sales (Trailing)

DHR Profitability

EBT Margin

25.82%

Return on Equity

13.47%

Return on Assets

8.15%

Free Cashflow Yield

3.91%

DHR Fundamentals

DHR Revenue

Revenue (TTM)

30.4B

Revenue Y/Y

-7.66%

Revenue Q/Q

-0.14%

DHR Earnings

Earnings (TTM)

6.4B

Earnings Y/Y

-34.17%

Earnings Q/Q

-23.72%

Price Action

52 Week Range

221.22283.63
(Low)(High)

Last 7 days

-1.5%

Last 30 days

0.0%

Last 90 days

4.8%

Trailing 12 Months

-7.0%

DHR Financial Health

Current Ratio

1.89

DHR Investor Care

Shares Dilution (1Y)

1.58%

Diluted EPS (TTM)

8.52

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for DHR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-21
Gutierrez-Ramos Jose-Carlos
sold
-147,819
250
-590
svp, chief science officer
2023-07-28
Raskas Daniel
sold
-2,922,650
260
-11,213
svp - corporate development
2023-07-28
Raskas Daniel
gifted
-
-
-385
svp - corporate development
2023-07-28
FILLER LINDA
sold
-2,651,980
260
-10,190
-
2023-07-28
SCHWIETERS JOHN T
sold (taxes)
-177,368
260
-682
-
2023-07-28
Zerhouni Elias A.
sold (taxes)
-177,368
260
-682
-
2023-07-28
Zerhouni Elias A.
acquired
177,292
50.8
3,490
-
2023-07-28
FILLER LINDA
acquired
172,895
59.17
2,922
-
2023-07-28
Raskas Daniel
acquired
635,777
56.7
11,213
svp - corporate development
2023-07-28
SCHWIETERS JOHN T
acquired
177,292
50.8
3,490
-

1–10 of 50

Which funds bought or sold DHR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-14
IMS Capital Management
added
0.45
-120,627
2,651,030
1.47%
2023-09-12
Farther Finance Advisors, LLC
added
6.67
7,152
460,829
0.10%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
added
11.63
683
11,523
-%
2023-09-07
Scarborough Advisors, LLC
unchanged
-
-99,426
1,981,920
0.47%
2023-09-07
ST GERMAIN D J CO INC
new
-
676,560
676,560
0.04%
2023-09-07
JAG CAPITAL MANAGEMENT, LLC
reduced
-1.71
-54,722
801,099
0.09%
2023-09-05
Westshore Wealth, LLC
new
-
268,800
268,800
0.14%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
-25.00
480
-%
2023-09-01
DYNAMO INTERNACIONAL GESTAO DE RECURSOS LTDA.
added
19.12
3,568,480
30,147,400
2.94%
2023-08-30
Western Wealth Management, LLC
added
1.99
-43,734
1,474,010
0.13%

1–10 of 46

Latest Funds Activity

Are funds buying DHR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own DHR
No. of Funds

Schedule 13G FIlings of Danaher

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
7.48%
54,428,553
SC 13G/A
Jan 31, 2023
blackrock inc.
7.1%
51,630,040
SC 13G/A
Mar 11, 2022
blackrock inc.
6.4%
45,990,561
SC 13G/A
Feb 09, 2022
vanguard group inc
6.99%
49,960,190
SC 13G/A
Feb 08, 2022
blackrock inc.
6.4%
45,990,561
SC 13G
Nov 02, 2021
rales mitchell p
4.99%
35,669,704
SC 13D/A
Jun 14, 2021
rales steven m
6.1%
43,454,958
SC 13D/A
Jun 14, 2021
rales mitchell p
5.0%
35,669,704
SC 13D/A
Feb 16, 2021
price t rowe associates inc /md/
4.4%
31,588,419
SC 13G/A
Feb 10, 2021
vanguard group inc
6.86%
48,739,681
SC 13G/A

Recent SEC filings of Danaher

View All Filings
Date Filed Form Type Document
Sep 19, 2023
8-K
Current Report
Sep 12, 2023
8-K
Current Report
Sep 11, 2023
3
Insider Trading
Aug 31, 2023
8-K
Current Report
Aug 31, 2023
8-K
Current Report
Aug 22, 2023
4
Insider Trading
Aug 21, 2023
144
Notice of Insider Sale Intent
Aug 15, 2023
8-K
Current Report
Aug 01, 2023
4
Insider Trading
Aug 01, 2023
4
Insider Trading

DHR Fair Value

Loading...

Peers (Alternatives to Danaher)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
184.3B
30.4B
-0.03% -7.02%
28.97
6.07
-1.49% 0.14%
108.0B
19.5B
3.26% 33.88%
39.87
5.55
10.36% 30.30%
107.1B
31.6B
-3.89% -5.40%
29.52
3.39
1.57% -30.40%
99.9B
6.7B
-0.98% 45.79%
70.1
14.99
11.75% -0.66%
42.7B
5.7B
-7.62% -17.65%
30.7
7.54
5.64% -4.53%
MID-CAP
9.6B
937.8M
-0.82% 34.59%
329.38
10.23
16.30% 250.21%
5.1B
1.1B
-5.56% -13.44%
24.39
4.67
12.63% 50.85%
3.1B
1.5B
-8.61% -11.74%
23.88
2.03
-1.37% -21.06%
1.9B
305.9M
-6.68% -50.77%
76.76
6.24
16.92% -25.89%
SMALL-CAP
608.4M
219.3M
-18.35% -22.36%
334.48
2.77
9.71% 216.45%
75.8M
11.7M
-22.92% -68.00%
-0.95
6.5
-12.19% -25.50%
50.7M
219.2M
14.43% -1.52%
12.8
0.23
22.12% 171.62%
5.8M
3.7M
-25.40% -68.58%
-0.47
1.58
27.23% -10.52%
2.9M
9.6M
-5.65% 484.42%
-0.2
0.3
-14.48% -52.98%

Danaher News

Nasdaq
Noteworthy ETF Outflows: IVW, ABBV, TMO, DHR.
Nasdaq,
6 hours ago
Investing.com UK

Returns for DHR

Cumulative Returns on DHR

17.3%


10-Year Cumulative Returns

18.7%


7-Year Cumulative Returns

18.6%


5-Year Cumulative Returns

6.9%


3-Year Cumulative Returns

Risks for DHR

What is the probability of a big loss on DHR?

47.3%


Probability that Danaher stock will be more than 20% underwater in next one year

0%


Probability that Danaher stock will be more than 30% underwater in next one year.

0%


Probability that Danaher stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does DHR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Danaher was unfortunately bought at previous high price.

Drawdowns

Financials for Danaher

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-1.9%30,35630,95031,47131,25030,81630,28329,45328,06526,72024,79922,28420,39218,88618,03417,91117,64717,44317,24617,04917,53017,884
Gross Profit-3.7%17,93418,61418,94918,95318,72818,40417,95216,96315,83014,28512,47511,22510,44010,0729,9849,8149,6829,5929,5059,81110,038
  S&GA Expenses1.3%8,6808,5718,5168,6208,5338,4148,1987,8617,5957,3146,8966,3885,9745,6795,5894,7334,9095,1575,3915,3705,310
  R&D Expenses-0.8%1,7201,7331,7451,7871,8081,8031,7421,6431,5441,4411,3481,2461,1861,1461,1269809981,0281,0591,0381,016
EBITDA-100.0%-8,9489,2419,1178,6038,5878,5548,0067,6277,0925,7095,1134,8264,4424,3524,052-----
EBITDA Margin-100.0%-0.29*0.29*0.29*1.61*0.28*0.29*0.29*0.29*0.29*0.26*0.25*0.25*0.23*0.23*0.20*-----
Interest Expenses7.1%24122521120322323423825427028627524719313510878.0095.00118137143141
Earnings Before Taxes-8.5%7,3147,9918,2928,1847,6407,6147,5987,0556,6895,8674,4953,9283,6943,2963,3052,9422,9572,9692,9622,9332,861
EBT Margin-100.0%-0.26*0.26*0.26*1.43*0.25*0.26*0.25*0.25*0.24*0.20*0.19*0.19*0.17*0.17*0.15*-----
Net Income-8.3%6,3606,9347,2096,7656,3516,4566,4335,8865,6114,7533,6463,6613,4463,2502,9892,4802,4762,4182,6512,7612,669
Net Income Margin-100.0%-0.22*0.23*0.22*1.19*0.21*0.22*0.21*0.21*0.19*0.16*0.18*0.18*0.17*0.15*0.13*-----
Free Cashflow-100.0%-7,3217,3677,0687,0517,1627,0647,0566,8766,3515,4174,4443,7543,4403,3173,479-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-0.2%84,90285,04084,35081,03081,80683,39283,18482,49878,02775,42676,16172,89171,26868,93062,08261,53153,32251,77447,83347,72048,056
  Current Assets5.6%17,46116,53215,88314,25013,22912,67011,64810,77615,39214,01213,80212,54112,34411,14325,59620,35411,60410,0807,0946,8316,913
    Cash Equivalents16.2%8,5757,3795,9955,1503,9843,7172,5862,5527,3226,3306,0355,6885,5394,36819,91214,2525,4343,910788776904
  Inventory-5.9%3,1833,3833,1103,2363,2573,0722,767---2,292---1,628---1,631--
  Net PPE2.7%4,1764,0653,9563,7193,7943,8153,7903,6403,4103,2663,2623,0522,9732,9892,3022,5202,5422,5042,2502,4622,493
  Goodwill-0.7%39,57639,85639,75238,25139,27640,66341,18441,23735,59034,88035,42034,27033,22733,72622,71325,72526,07526,00122,58126,03525,917
  Current Liabilities-3.7%8,4048,7308,3898,0027,5567,5478,1407,2576,8256,8247,4026,0385,6008,4664,9325,9345,0084,6334,8424,4654,605
    LT Debt, Non Current0.1%18,28518,26119,08618,54220,05221,76822,16823,59120,40020,26721,19321,80622,37022,73721,51716,53610,1449,4589,68910,55811,146
Shareholder's Equity0.5%51,71651,47850,08246,98546,60146,36245,16743,46142,76640,43039,77737,97236,27331,06630,28233,19632,21331,56928,22527,68527,224
  Retained Earnings2.2%41,34440,43739,20537,17735,80834,33232,82731,23130,26428,67027,15926,08825,37424,60924,16626,48125,95525,36925,16324,52923,977
  Additional Paid-In Capital14.9%13,93912,13012,07211,98511,85410,12310,09010,0049,8909,7949,6989,6189,4757,6307,5657,5027,4837,3765,8345,7725,706
Accumulated Depreciation2.4%4,1204,0223,8933,6273,5383,5173,4653,3903,3313,2123,1823,0392,8812,7402,7613,0232,9992,9062,8282,7402,689
Shares Outstanding1.2%738729728728727716715715715713711711705697696719718708702701700
Minority Interest0%8.008.008.008.007.006.0010.0010.0010.0011.0011.0012.0011.0011.0011.0069312.0012.0012.0012.0012.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-0.9%8,4248,4988,5198,3118,3358,4558,3588,2467,9357,2606,2085,0994,3414,0683,9524,0784,0323,8964,0223,6193,772
  Share Based Compensation2.4%343335336329292244218209202196187179175169159144141140138134129
Cashflow From Investing-1.5%-2,066-2,035-2,234-2,297-11,830-12,497-12,987-12,689-2,970-1,364-21,239-20,924-20,839-21,607-1,238-1,269-1,311-3,324-2,949-2,967-2,835
Cashflow From Financing37.2%-1,606-2,558-2,570-3,0864491,4701,2951,297-3,327-4,0771,0067,18116,62718,12116,36510,6961,8352,403-797-436-732
  Dividend Payments-0.2%829831818806793764742721692646615587576553527497458448433419404

DHR Income Statement

2023-06-30
Consolidated Condensed Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jul. 01, 2022
Jun. 30, 2023
Jul. 01, 2022
Income Statement [Abstract]    
Sales$ 7,157$ 7,751$ 14,324$ 15,439
Cost of sales(3,116)(3,030)(5,913)(6,013)
Gross profit4,0414,7218,4119,426
Operating costs:    
Selling, general and administrative expenses(2,194)(2,085)(4,341)(4,177)
Research and development expenses(418)(431)(847)(872)
Operating profit1,4292,2053,2234,377
Nonoperating income (expense):    
Other income (expense), net(29)(87)(5)(107)
Interest expense(67)(51)(135)(105)
Interest income5921073
Earnings before income taxes1,3922,0693,1904,168
Income taxes(286)(389)(634)(763)
Net earnings1,1061,6802,5563,405
Mandatory convertible preferred stock dividends0(22)(21)(63)
Net earnings attributable to common stockholders$ 1,106$ 1,658$ 2,535$ 3,342
Net earnings per common share:    
Basic (in usd per share)$ 1.50$ 2.28$ 3.46$ 4.63
Diluted (in usd per share)$ 1.49$ 2.25$ 3.42[1]$ 4.56
Average common stock and common equivalent shares outstanding:    
Basic (in shares)737.3726.7733.4721.5
Diluted (in shares)744.7736.0740.2736.8
[1]Net earnings per common share amounts for the relevant three-month periods do not add to the six-month period amount due to rounding.

DHR Balance Sheet

2023-06-30
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and equivalents$ 8,575$ 5,995
Trade accounts receivable, less allowance for doubtful accounts of $130 and $126, respectively4,1994,918
Inventories:  
Finished goods1,5201,504
Work in process528473
Raw materials1,1351,133
Total inventories3,1833,110
Prepaid expenses and other current assets1,5041,860
Total current assets17,46115,883
Property, plant and equipment, net of accumulated depreciation of $4,120 and $3,893, respectively4,1763,956
Other long-term assets4,3724,459
Goodwill39,57639,752
Other intangible assets, net19,31720,300
Total assets84,90284,350
Current liabilities:  
Notes payable and current portion of long-term debt1,590591
Trade accounts payable1,9562,296
Accrued expenses and other liabilities4,8585,502
Total current liabilities8,4048,389
Other long-term liabilities6,4896,785
Long-term debt18,28519,086
Stockholders’ equity:  
Preferred stock01,668
Common stock99
Additional paid-in capital13,93912,072
Retained earnings41,34439,205
Accumulated other comprehensive income (loss)(3,576)(2,872)
Total Danaher stockholders’ equity51,71650,082
Noncontrolling interests88
Total stockholders’ equity51,72450,090
Total liabilities and stockholders’ equity$ 84,902$ 84,350
Rainer M. Blair
65535
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.